@Ashton_1nvests $RDGL has more potential to stop cancer in it's tracks! It is a ground floor opportunity to save lives and create generational health for share holders, thus has the most upside potential over the next 5 years. 8 cents per share
โRecord day + IDE window open = perfect de-risking for $RDGL investors. IsoPet revenue is already scaling while the human path accelerates. $RDGL NFA DYOR
Capital Veterinary Specialists just broke the record for pets treated in one day by successfully treating 8 patients with IsoPetยฎ Precision Radionuclide Therapyโข. CVS is using a new Margin Therapy protocol to expand treatment options for cancer care. $RDGL
March Madness kicks off โ but in biotech, the real tournament is catalysts and execution! ๐๐
$RDGL is entering the bracket with:
โข Pending DCGI approval in India for expanded trials
โข IDE submission targeted end-Q1/April
โข New manufacturing sites (WA + India) scaling up
At a tiny market cap, this is high-stakes upside. Who's your "Final Four" pick for $RDGL catalysts this month? Reply below!
#RDGL #MarchMadness #Biotech #RadioGel